NewGene Looks to Shake up BRCA Market with Next-gen Sequencing-based Test | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – A UK firm founded three years ago is looking to shake up the BRCA testing market.

In mid-2010, NewGene, based in Newcastle upon Tyne, launched its next-generation sequencing-based BRCA1 and BRCA2 testing service for breast cancer in the UK. Initially, the test is being targeted to patients with a family history of breast cancer with a longer-term goal of developing it as a general screen for the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.